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Purpose: To investigate the genetic basis of Marinesco-Sjogren syndrome (MSS) in consanguineous Pakistani families.
Methods: Two consanguineous Pakistani families with congenital cataract and muscular dystrophy were enrolled for this
study. Detailed ophthalmic and systemic examination including slit lamp microscopy, electromyogram and computed
tomography scans were performed to characterize the syndrome. Blood samples were collected from affected and
unaffected individuals and a genome wide scan consisting of 382 polymorphic microsatellite markers was performed.
Coding exons, exon-intron boundaries, 5’ UTR, and 3’ UTR of the candidate gene SIL1 residing in the linkage interval
was sequenced bi-directionally.
Results: Clinical examination of the affected members of families 60067 and 60078 revealed features of MSS. The linked
interval at chromosome 5q31 harbors SIL1. Sequencing of SIL1 in family 60067 revealed a homozygous substitution;
c1240C>T,  leading  to  a  premature  substitution; p.Q414X.  Similarly,  sequencing  of  SIL1  in  family  60078 identified a
homozygous change; c.274C>T, leading to a non conservative substitution; p.R92W.
Conclusion: In conclusion, our data report two novel missense mutations in two consanguineous Pakistani families
affected with MSS.
Congenital cataracts are one of the major causes of vision
loss in children worldwide and are responsible for about one
third of blindness in infants [1,2]. Cataract can be classified
according  to  etiology,  as  environmental,  hereditary,  or
traumatic  cataract.  Hereditary  cataract  may  occur  in  an
isolated  fashion  or  a  part  of  any  syndrome.  Marinesco–
Sjogren  syndrome  (MSS)  is  a  rare  autosomal  recessive
multisystem disorder. The classical characteristics of MSS
include cerebellar ataxia, short stature, mental retardation and
cataracts.  Additionally,  skeletal  abnormalities,  nystagmus,
hypotonia, dysarthria, and strabismus are reported in MSS
patients. MSS was first described in 1931 by Marinesco in a
family  of  Romanian  origin  and  further  characterized  by
Sjogren in families of Swedish origin [3].
Lagier-Tourenne  and  colleagues  mapped  the  disease
locus  to   chromosome   5q31  by   homozygosity   mapping   in 
2003 [4].  In  2005,  mutations  in  SIL1 were identified in
individuals  with  MSS  [5].  Further,  four  MSS  associated
loss-of-function  mutations  in  SIL1  leading   to   disturbed 
SIL1-HSPA5 interaction and protein folding were identified
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[6,7].     Additionally,   since    the   original    reports,    novel  
mutations in SIL1 have been identified in extended pedigrees
[8,9]. However, some patients with typical MSS do not have
identifiable mutations in SIL1, implying genetic heterogeneity
[5].
SIL1 is a 461 amino-acid protein that has a potential
NH2-terminal ER targeting sequence and a COOH-terminal
tetrapeptide, most likely an ER retrieval sequence [10]. SIL1
is ubiquitously expressed and acts as an adenine nucleotide
exchange factor for the heat-shock protein chaperone GRP78,
a molecular chaperone functioning mainly in the endoplasmic
reticulum [10,11]. SIL1 regulates the ATPase cycle of GRP78
and  has  thus  been  anticipated  to  be  involved  in  protein
translocation  into  the  ER,  proper  folding  of  the  newly
synthesized  proteins  and  regulating  the  degradation  of
proteins that fail to mature properly [12].
Here,  we  report  consanguineous  Pakistani  families,
60067 and 60078, ascertained from the Punjab province in
Pakistan.  The  clinical  diagnosis  confirmed  that  cataracts
segregated in both families in an autosomal recessive fashion.
In addition to congenital cataracts affected individuals also
exhibited  typical  myopathic  features.  During  the  genome
scan, linkage was established to chromosome 5q31 markers
in both families. Sequencing of SIL1 in family 60067 revealed
a  homozygous  substitution,  leading  to  a  premature
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1050termination. Similarly, sequencing of SIL1 in family 60078
identified  a  homozygous  change  that  results  in  a  non
conservative substitution. These results suggest homozygous
substitutions  in  the  SIL1  are  responsible  for  MSS  in
consanguineous Pakistani families.
METHODS
Clinical  ascertainment:  One  hundred  consanguineous
Pakistani families with non-syndromic cataract were recruited
to participate in a collaborative study between the National
Center of Excellence in Molecular Biology, Lahore, Pakistan
and the National Eye Institute, NIH, Bethesda, MD, to identify
new disease loci. IRB approval was obtained for this study
from the National Eye Institute and the Centre of Excellence
in  Molecular  Biology.  The  participating  subjects  gave
informed consent consistent with the tenets of the Declaration
of Helsinki. The families described in this study are from the
Punjab province of Pakistan. A detailed medical history was
obtained  by  interviewing  family  members.  Ophthalmic
examinations including slit lamp microscopy were conducted
to indentify the cataract phenotype. Creatine phosphokinase
and aldolase kinase levels were measured through blood test
performed  at  the  Zeenat  laboratory,  Lahore,  Pakistan.  An
electromyogram (EMG) was performed at the Mayo Hospital,
Lahore, Pakistan to detect abnormal muscle electrical activity
that can occur in many diseases and conditions, including
muscular  dystrophy,  inflammation  of  muscles,  pinched
nerves, and peripheral nerve damage. Computed tomography
(CT) scans were performed at Children Hospital, Lahore,
Pakistan. The images were analyzed by  doctors at the children
hospital  to  evaluate  cerebellar  hypoplasia.  Blood  samples
were collected from affected and unaffected family members.
DNA was extracted by a non organic method as described by
Grimberg et al. [13].
Genotype Analysis: A genome wide scan was performed with
382 highly polymorphic fluorescent markers from the ABI
PRISM Linkage Mapping Set MD-10 (Applied Biosystems,
Foster  City,  CA)  having  an  average  spacing  of  10  cM.
Multiplex polymerase chain reactions (PCR) were carried out
using a GeneAmp PCR System 9700 (Applied Biosystems).
Briefly,  each  reaction  was  carried  out  in  a  5  μl  mixture
containing 40 ng genomic DNA, various combinations of 10
μM-dye-labeled  primer  pairs,  0.5  μl  10X  GeneAmp  PCR
Buffer  II,  0.5  μl  10mM  Gene  Amp  dNTP  mix,  2.5  mM
MgCl2, and 0.2 U of Taq DNA polymerase (AmpliTaq Gold
Enzyme;  Applied  Biosystems).  Initial  denaturation  was
carried out for 5 min at 95 ºC, followed by 10 cycles of 15 s
at 94 ºC, 15 s at 55 ºC and 30 s at 72 ºC and then 20 cycles of
15 s at 89 ºC, 15 s at 55 ºC and 30 s at 72 ºC. The final extension
was performed for 10 min at 72 ºC and followed by a final
hold at 4 ºC. PCR products from each DNA sample were
pooled and mixed with a loading cocktail containing HD-400
size standards (Applied Biosystems) and loading dye. The
resulting  PCR  products  were separated  in  an  ABI  3100
DNA  analyzer  and  alleles  were assigned using GeneScan
(version 3.7; Applied Biosystems) and Genotyper Software
(version 3.7; Applied Biosystems).
Linkage  Analysis:  Two  point  linkage  analyses  were
performed using the FASTLINK version of MLINK from the
LINKAGE Program Package [14,15]. Maximum LOD scores
were calculated using ILINK. Autosomal recessive cataract
was analyzed as a fully penetrant trait with an affected allele
frequency of 0.001. The marker order and distances between
the markers were obtained from the Marshfield database and
the  National  Center  for  Biotechnology  Information
chromosome 5 sequence maps. For the initial genome scan
equal allele frequencies were assumed, while for fine mapping
allele frequencies were estimated from 125 unrelated and
unaffected individuals from the Punjab province of Pakistan.
Mutation Screening: Primer pairs for individual exons were
designed  using  the  primer3  program.  The  sequences  and
annealing  temperatures  are  available  upon  request.
Amplifications were performed in 25 ul reactions containing
50 ng of genomic DNA, 8 picomoles each primer, 2.5 mM
dNTP, 2.5 mM MgCl2, and 0.2 U Taq DNA polymerase in the
standard  1X  PCR  buffer  provided  by  the  manufacturer
(AmpliTaq  Gold  Enzyme;  Applied  Biosystems)  PCR
amplification consisted of a denaturation step at 96 °C for 5
min, followed by 40 cycles, each consisting of 96 °C for 45 s
followed by 57 °C for 45 s and at 72 °C for 1 min. PCR
products were analyzed on 2% agarose gel, precipitated and
purified by ethanol precipitation. The PCR primers for each
exon were used for bidirectional sequencing using Big Dye
Terminator  Ready  reaction  mix  according  to  the
manufacturer’s  instructions  (Applied  Biosystems).
Sequencing  products  were  re-suspended  in  10  μl  of
Figure 1. Slit lamp microscopy of bilateral membranous cataract. In
family 60067 slit lamp microscopy revealed bilateral membranous
cataracts in affected individual 11.
Molecular Vision 2009; 15:1050-1056 <http://www.molvis.org/molvis/v15/a111> © 2009 Molecular Vision
1051formamide (Applied Biosystems) and denatured at 95 ºC for
5 min. Sequencing was performed on an ABI PRISM 3100
Automated  sequencer  (Applied  Biosystems).  Sequencing
results  were  assembled  ABI  PRISM  sequencing  analysis
software version 3.7 and analyzed using Chromas software
version 1.45.
RESULTS
Two  large  consanguineous  families  (60067  and  60078),
comprising multiple affected individuals, were recruited from
the Punjab province of Pakistan. A detailed medical history
was obtained by interviewing members of both families. The
ophthalmic  clinical  records  in  both  families  revealed  that
cataracts in affected individuals developed in the early years
of their life. In family 60067 slit lamp microscopy revealed
bilateral  membranous  cataracts  in  affected  individual  11
(Figure 1). The clinical records further confirmed that the rest
of  the  affected  individuals  had  bilateral  membranous
cataracts.  In  addition,  the  ophthalmic  records  revealed
nystagmus,  bilateral  esotropia,  and  inward  convergent
deviation  or  inward  deviation  in  the  affected  individuals.
Skeletal abnormalities, ataxia, muscular dystrophy, mild to
moderate mental retardation, dysarthria, and hypogonadism
were confirmed in affected individuals of family 60067. The
CK  test  confirmed  higher  than  normal  levels  of  creatine
phosphokinase in affected individuals whereas aldolase levels
were found to be within normal range for affected individuals
(Table  1).  The  Electromyogram  (EMG)  revealed  no
TABLE 1. CLINICAL CHARACTERISTICS OF AFFECTED INDIVIDUALS OF FAMILY 60067.
Clinical characteristics Individual 10 Individual 11 Individual 17 Individual 18 Individual 19
Sex M M M F F
Age
(at examination)
9 years 6 years 12 years 17 years 19 years
Cataract
(Age of onset)
after 2 year after 2year after 2 year after 3 year after 3year
Cataract
(phenotype)
Membranous
cataract
Membranous
cataract
Membranous
cataract
Membranous
cataract
Membranous
cataract
Nystagmus + + + + +
Ataxia + + + + +
Mental retardation + + + + +
Hypogonadism NT NT NT + +
Serum CK 393.1 NT NT 258 NT
Aldolase test 6.8 NT NT 6.3 NT
Myopathic EMG Muscular Dystrophy NT NT Muscular dystrophy NT
Cerebellar atrophy NT NT NT NT NT
Dysarthria + + + + +
Short stature NT NT NT + +
Skeletal abnormalities NT NT NT + +
EMG, electromyogram; CK, Creatine Phosphokinase; NT, not determined.
TABLE 2. CLINICAL CHARACTERISTICS OF AFFECTED INDIVIDUALS OF FAMILY 60078.
Clinical characteristics Individual 9 Individual 10 Individual 12 Individual 13 Individual 15 Individual 16
Sex M F M M M M
Age
(at examination)
13 years 8 years 12 years 14 years 15 years 17 years
Cataract
(Age at diagnosis)
Congenital Congenital Congenital Congenital Congenital Congenital
Cataract
(phenotype)
Operated Cortical cataract Operated Operated Operated Operated
Nystagmus _ _ _ + + +
Ataxia + + + + + +
Mental retardation + + + + + +
Hypogonadism NT NT NT NT NT NT
Serum CK 516.00 270.00 NT NT NT NT
Aldolase test 11.80 7.90 NT NT NT NT
Myopathic EMG Muscular dystrophy Muscular dystrophy NT NT NT NT
Cerebellar atrophy + + NT NT NT NT
Dysarthria + + + + + +
Short stature + + + + + +
Skeletal abnormalities + + + + + +
EMG, electromyogram; CK, Creatine Phosphokinase; NT, not determined.
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1052spontaneous activity of early and/or full recruitment pattern
with myogenic motor units of low amplitude and small in
duration. These electrophysiological studies are indicative of
non-inflammatory myopathy (muscular dystrophy).
In  family  60078  all  affected  individuals  underwent
cataract surgery during the early years of their life, hence no
photograph  of  the  cataractous  lenses  were  available.
However, the clinical report for one (individual ID 9) of the
two affected individuals with slit lamp microscopy revealed
cortical cataract. No information regarding the phenotype of
cataract was available for the other affected individuals. All
the affected individuals of 60078 can’t stand or walk without
support.  Further,  mild  mental  retardation,  short  stature,
microcephaly,  and  myopahty  were  confirmed  in  affected
individuals of family 60078. The results confirmed higher
levels of creatine phosphokinase in both affected individuals
(ID 9 and 10) of 60078 whereas higher than normal aldolase
levels were found in one of the two affected individuals (Table
2). The EMG studies revealed no spontaneous activity of early
and/or full recruitment pattern with myogenic motor units in
the tested muscles indicative of non inflammatory myopathy
in both affected individuals. The results for the CT scan for
both affected individuals revealed that the posterior fossa
were comparatively small, dilated 4th ventricle, and extra-
ventricular  CSF  spaces  in  the  posterior  fossa  showed
prominent folia and enlarged cisterna magna, whereas the
third and lateral ventricles were normal without any evidence
of intra/extra axial mass or hemorrhage (Figure 2). Taken
together these results are indicative of cerebellar hypoplasia.
Figure 2. Computed tomography (CT) scan results of individual 09,
family  60078.  A  depicts  cerebellar  dysgenesis/atrophy,  reduced
density of cerebellar cortex and atrophy of superior vermis, while B
shows dilation of the 4th ventricle, lack of communication between
4th ventricle and Cisterna Magna and absence of Posterior inferior
part of vermis. C shows the absence of inferior limit of vermis and
cerebellar cortical atrophy and D demonstrates reduced density of
the cerebellar cortex.
A genome-wide scan was completed with 382 highly
polymorphic  STR  markers.  Linkage  was  observed  with
markers at chromosome 5q for both families (Table 3 and
Table  4).  Significant  LOD  scores  of  3.22  and  3.08  were
observed  with  D5S2110  and  D5S2117  for  family  60067
(Table 3). Similarly, significant LOD scores of 5.14, 4.02 and
3.80 were obtained with D5S2011, D5S436, and D5S2090 for
family 60078 (Table 4). Visual inspection of the haplotypes
supports the results and confirms linkage to chromosome 5q
(Figure 3). All the affected individuals are homozygous for
D5S2070,  D5S2110,  D5S2117,  and  D5S2115  in  family
60067; whereas the unaffected individuals are heterozygous
carriers of the disease allele or homozygous for the normal
alleles. Similarly, in family 60078, all the affected individuals
are  homozygous  for  D5S2011,  D5S436,  D5S2090  and
D5S410; whereas the unaffected individuals are heterozygous
carriers of the disease allele or homozygous for the normal
alleles.
SIL1 lies on chromosome 5q31 and consists of 9 coding
exons, generating a transcript of 1,895 bp that results in a 461
amino acid protein. We sequenced all coding exons, exon-
intron boundaries and the 5’ and 3’ UTR regions of SIL1.
Sequencing of SIL1 in family 60067 revealed a homozygous
substitution; c1240C>T, leading to a premature termination;
p.Q414X  (Figure  4A-C).  All  affected  individuals  were
homozygous  for  the  C>T  transition;  whereas  unaffected
individuals 5, 6, 7, 8, 15, 16, 21, and 22 were heterozygous
for  the  transition.  Unaffected  individuals  9  and  20  are
homozygous for the wild type allele. Similarly, sequencing of
SIL1 in family 60078 identified a homozygous change; c.
274C>T, leading to a non conservative substitution; p.R92W
(Figure 4D,E). All affected individuals were homozygous for
the C>T transition; whereas unaffected individuals 3, 7, 8, 11,
14, 17, and 18 were heterozygous for the transition. These
sequence variants were not found in 96 ethically matched
samples from Punjab province of Pakistan.
DISCUSSION
Here  we  report  two  consanguineous  Pakistani  families
characterized by autosomal recessive congenital and typical
myopathic symptoms recruited from the Punjab province of
Pakistan.  Linkage  analysis  with  382  polymorphic  STR
markers localized the critical interval to chromosome 5q31.
Sequencing of SIL1 indentified one non-sense and a missense
mutation  segregating  with  the  disease  phenotype  in  the
respective families. None of these variations were present in
96 ethnically matched samples from the Punjab province of
Pakistan.  Statistically  significant  LOD  scores  with
chromosome 5q31 STR markers, segregation of the mutations
with the disease phenotype in both families and absence in the
ethnically similar control samples strongly suggests that these
mutations in SIL1 are responsible for the disease phenotype
in both families.
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.These  families  were  recruited  to  participate  in  a
Figure 3. Pedigree drawings of family 60067 (A) and 60078 (B) are
shown. Squares are males, circles are females, filled symbols are
affected  individuals,  double  line  between  individuals  indicates
consanguinity, and diagonal line through a symbol is deceased family
member.  The  haplotypes  of  11  adjacent  chromosome  5q31
microsatellite  markers  are  shown  with  alleles  forming  the  risk
haplotype are shaded black, alleles co-segregating with phenotype
but not showing homozygosity are shaded grey and alleles not co-
segregating with disease phenotype are shown in white.
collaborative  study  to  investigate  recessive  congenital
cataracts. Initially, an ophthalmic evaluation was performed
in Pakistan that confirmed the presence of cataracts in both
families and later genome wide scans were completed jointly
at the National Center of Excellence in Molecular Biology,
Pakistan and the National Eye Institute, USA. After linkage
was  established  at  5q31  and  mutations  were  identified  in
SIL1,  affected  individuals  in  both  families  underwent  a
thorough clinical examination, which confirmed that affected
individuals in both families exhibit cardinal features of MSS.
One of the two mutations reported here, Q414X is present in
the last exon. As there is no exon-intron boundary present
downstream of the non-sense mutation, the mutant transcript
is expected to not be degraded by the non-sense mediated
decay, which will result in a protein that lacks 46 amino acids
of  its  COOH-terminal.  The  COOH-terminus  of  the  SIL1
protein harbors the tetrapeptide, KELR that is most likely an
ER retrieval sequence. We thus hypothesize that the Q414X
mutant protein is likely to lead to defective retrieval of the
secretory pathway.
A  majority  of  the  reported  mutations  in  SIL1  are
responsible for the MSS phenotype resulting from a premature
termination  of  the  protein.  L457P  is  the  only  missense
mutation reported that results in MSS [6]. We identified a
Figure  4.  Sequence  chromatograms  of  SIL1.  A:  Unaffected
individual 09 in family 60067 homozygous for the wild type allele.
B: Unaffected individual 06 in family 60067 heterozygous and C;
affected individual 10 homozygous for the c.1240 C>T transition,
leading  to  a  premature  termination  p.Q414X.  D:  unaffected
individual  14  of  family  60078  heterozygous  and  E:  affected
individual 15 homozygous for the c.274 C>T transition, leading to a
premature substitution; p.R92W.
Molecular Vision 2009; 15:1050-1056 <http://www.molvis.org/molvis/v15/a111> © 2009 Molecular Vision
1055R92W mutation segregating with the disease phenotype in
family 60078. The Arg92 is conserved among higher primates
and hence the substitution of a positively charged amino acid
with an amino acid harboring an aromatic ring is bound to
influence the protein tertiary structure and this may affect the
SIL1 protein function leading to the disease phenotype in this
Pakistani family.
To-date, 18 mutations have been reported in SIL1 protein
that result in the MSS phenotype. This is the first report
describing  patients  with  the  MSS  phenotype  linked  with
mutations  in  SIL1  in  families  of  Pakistani  origin.
Identification  of  the  specific  mutations  in  SIL1  and  the
phenotype  of  MSS  associated  with  these  mutations  will
increase our understanding of the syndrome at the molecular
level.
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